MAPK3 and ovarian cancer: Furthermore, it has been shown that in ovarian cancer, the high levels of ROS are usually found to be combined with the absence of endogenous MKP3 which finally leads to activation of Erk1/2 and induction of cell proliferation as shown in Figure 3 [27].